Metformin promotes angiogenesis and functional recovery in aged mice after spinal cord injury by adenosine monophosphate-activated protein kinase/endothelial nitric oxide synthase pathway

Treatment with metformin can lead to the recovery of pleiotropic biological activities after spinal cord injury. However, its effect on spinal cord injury in aged mice remains unclear. Considering the essential role of angiogenesis during the regeneration process, we hypothesized that metformin acti...

Full description

Bibliographic Details
Main Authors: Jin-Yun Zhao, Xiao-Long Sheng, Cheng-Jun Li, Tian Qin, Run-Dong He, Guo-Yu Dai, Yong Cao, Hong-Bin Lu, Chun-Yue Duan, Jian-Zhong Hu
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Neural Regeneration Research
Subjects:
Online Access:http://www.nrronline.org/article.asp?issn=1673-5374;year=2023;volume=18;issue=7;spage=1553;epage=1562;aulast=Zhao
_version_ 1797954763949604864
author Jin-Yun Zhao
Xiao-Long Sheng
Cheng-Jun Li
Tian Qin
Run-Dong He
Guo-Yu Dai
Yong Cao
Hong-Bin Lu
Chun-Yue Duan
Jian-Zhong Hu
author_facet Jin-Yun Zhao
Xiao-Long Sheng
Cheng-Jun Li
Tian Qin
Run-Dong He
Guo-Yu Dai
Yong Cao
Hong-Bin Lu
Chun-Yue Duan
Jian-Zhong Hu
author_sort Jin-Yun Zhao
collection DOAJ
description Treatment with metformin can lead to the recovery of pleiotropic biological activities after spinal cord injury. However, its effect on spinal cord injury in aged mice remains unclear. Considering the essential role of angiogenesis during the regeneration process, we hypothesized that metformin activates the adenosine monophosphate-activated protein kinase/endothelial nitric oxide synthase pathway in endothelial cells, thereby promoting microvascular regeneration in aged mice after spinal cord injury. In this study, we established young and aged mouse models of contusive spinal cord injury using a modified Allen method. We found that aging hindered the recovery of neurological function and the formation of blood vessels in the spinal cord. Treatment with metformin promoted spinal cord microvascular endothelial cell migration and blood vessel formation in vitro. Furthermore, intraperitoneal injection of metformin in an in vivo model promoted endothelial cell proliferation and increased the density of new blood vessels in the spinal cord, thereby improving neurological function. The role of metformin was reversed by compound C, an adenosine monophosphate-activated protein kinase inhibitor, both in vivo and in vitro, suggesting that the adenosine monophosphate-activated protein kinase/endothelial nitric oxide synthase pathway likely regulates metformin-mediated angiogenesis after spinal cord injury. These findings suggest that metformin promotes vascular regeneration in the injured spinal cord by activating the adenosine monophosphate-activated protein kinase/endothelial nitric oxide synthase pathway, thereby improving the neurological function of aged mice after spinal cord injury.
first_indexed 2024-04-10T23:23:43Z
format Article
id doaj.art-fe5f7ba85664418c92a45648ce18dd01
institution Directory Open Access Journal
issn 1673-5374
language English
last_indexed 2024-04-10T23:23:43Z
publishDate 2023-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Neural Regeneration Research
spelling doaj.art-fe5f7ba85664418c92a45648ce18dd012023-01-12T13:29:30ZengWolters Kluwer Medknow PublicationsNeural Regeneration Research1673-53742023-01-011871553156210.4103/1673-5374.360245Metformin promotes angiogenesis and functional recovery in aged mice after spinal cord injury by adenosine monophosphate-activated protein kinase/endothelial nitric oxide synthase pathwayJin-Yun ZhaoXiao-Long ShengCheng-Jun LiTian QinRun-Dong HeGuo-Yu DaiYong CaoHong-Bin LuChun-Yue DuanJian-Zhong HuTreatment with metformin can lead to the recovery of pleiotropic biological activities after spinal cord injury. However, its effect on spinal cord injury in aged mice remains unclear. Considering the essential role of angiogenesis during the regeneration process, we hypothesized that metformin activates the adenosine monophosphate-activated protein kinase/endothelial nitric oxide synthase pathway in endothelial cells, thereby promoting microvascular regeneration in aged mice after spinal cord injury. In this study, we established young and aged mouse models of contusive spinal cord injury using a modified Allen method. We found that aging hindered the recovery of neurological function and the formation of blood vessels in the spinal cord. Treatment with metformin promoted spinal cord microvascular endothelial cell migration and blood vessel formation in vitro. Furthermore, intraperitoneal injection of metformin in an in vivo model promoted endothelial cell proliferation and increased the density of new blood vessels in the spinal cord, thereby improving neurological function. The role of metformin was reversed by compound C, an adenosine monophosphate-activated protein kinase inhibitor, both in vivo and in vitro, suggesting that the adenosine monophosphate-activated protein kinase/endothelial nitric oxide synthase pathway likely regulates metformin-mediated angiogenesis after spinal cord injury. These findings suggest that metformin promotes vascular regeneration in the injured spinal cord by activating the adenosine monophosphate-activated protein kinase/endothelial nitric oxide synthase pathway, thereby improving the neurological function of aged mice after spinal cord injury.http://www.nrronline.org/article.asp?issn=1673-5374;year=2023;volume=18;issue=7;spage=1553;epage=1562;aulast=Zhaoadenosine monophosphate-activated protein kinase/endothelial nitric oxide synthase pathway; angiogenesis; aged mice; compound c; metformin; spinal cord injury
spellingShingle Jin-Yun Zhao
Xiao-Long Sheng
Cheng-Jun Li
Tian Qin
Run-Dong He
Guo-Yu Dai
Yong Cao
Hong-Bin Lu
Chun-Yue Duan
Jian-Zhong Hu
Metformin promotes angiogenesis and functional recovery in aged mice after spinal cord injury by adenosine monophosphate-activated protein kinase/endothelial nitric oxide synthase pathway
Neural Regeneration Research
adenosine monophosphate-activated protein kinase/endothelial nitric oxide synthase pathway; angiogenesis; aged mice; compound c; metformin; spinal cord injury
title Metformin promotes angiogenesis and functional recovery in aged mice after spinal cord injury by adenosine monophosphate-activated protein kinase/endothelial nitric oxide synthase pathway
title_full Metformin promotes angiogenesis and functional recovery in aged mice after spinal cord injury by adenosine monophosphate-activated protein kinase/endothelial nitric oxide synthase pathway
title_fullStr Metformin promotes angiogenesis and functional recovery in aged mice after spinal cord injury by adenosine monophosphate-activated protein kinase/endothelial nitric oxide synthase pathway
title_full_unstemmed Metformin promotes angiogenesis and functional recovery in aged mice after spinal cord injury by adenosine monophosphate-activated protein kinase/endothelial nitric oxide synthase pathway
title_short Metformin promotes angiogenesis and functional recovery in aged mice after spinal cord injury by adenosine monophosphate-activated protein kinase/endothelial nitric oxide synthase pathway
title_sort metformin promotes angiogenesis and functional recovery in aged mice after spinal cord injury by adenosine monophosphate activated protein kinase endothelial nitric oxide synthase pathway
topic adenosine monophosphate-activated protein kinase/endothelial nitric oxide synthase pathway; angiogenesis; aged mice; compound c; metformin; spinal cord injury
url http://www.nrronline.org/article.asp?issn=1673-5374;year=2023;volume=18;issue=7;spage=1553;epage=1562;aulast=Zhao
work_keys_str_mv AT jinyunzhao metforminpromotesangiogenesisandfunctionalrecoveryinagedmiceafterspinalcordinjurybyadenosinemonophosphateactivatedproteinkinaseendothelialnitricoxidesynthasepathway
AT xiaolongsheng metforminpromotesangiogenesisandfunctionalrecoveryinagedmiceafterspinalcordinjurybyadenosinemonophosphateactivatedproteinkinaseendothelialnitricoxidesynthasepathway
AT chengjunli metforminpromotesangiogenesisandfunctionalrecoveryinagedmiceafterspinalcordinjurybyadenosinemonophosphateactivatedproteinkinaseendothelialnitricoxidesynthasepathway
AT tianqin metforminpromotesangiogenesisandfunctionalrecoveryinagedmiceafterspinalcordinjurybyadenosinemonophosphateactivatedproteinkinaseendothelialnitricoxidesynthasepathway
AT rundonghe metforminpromotesangiogenesisandfunctionalrecoveryinagedmiceafterspinalcordinjurybyadenosinemonophosphateactivatedproteinkinaseendothelialnitricoxidesynthasepathway
AT guoyudai metforminpromotesangiogenesisandfunctionalrecoveryinagedmiceafterspinalcordinjurybyadenosinemonophosphateactivatedproteinkinaseendothelialnitricoxidesynthasepathway
AT yongcao metforminpromotesangiogenesisandfunctionalrecoveryinagedmiceafterspinalcordinjurybyadenosinemonophosphateactivatedproteinkinaseendothelialnitricoxidesynthasepathway
AT hongbinlu metforminpromotesangiogenesisandfunctionalrecoveryinagedmiceafterspinalcordinjurybyadenosinemonophosphateactivatedproteinkinaseendothelialnitricoxidesynthasepathway
AT chunyueduan metforminpromotesangiogenesisandfunctionalrecoveryinagedmiceafterspinalcordinjurybyadenosinemonophosphateactivatedproteinkinaseendothelialnitricoxidesynthasepathway
AT jianzhonghu metforminpromotesangiogenesisandfunctionalrecoveryinagedmiceafterspinalcordinjurybyadenosinemonophosphateactivatedproteinkinaseendothelialnitricoxidesynthasepathway